NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to YESMRO Holdings Limited for its overseas listing, requiring supplementary explanations and legal opinions on 8 items including round-trip M&A compliance, new shareholders within the last 12 months, control identification, shareholder look-through and nominee shareholding, and equity incentives; the regulator specifically requires verification of the share repurchase and transfer in January 2026, the look-through of 5% shareholder Shanghai Lingyi and historical nominee shareholding arrangements.
NewTimeSpace News: On 14 August 2026, the CSRC International Department issued supplementary filing requirements to Ruike Xianjin for its overseas listing, requiring supplementary explanations and legal opinions on 7 items including round-trip M&A compliance, the restructuring progress of Ruihua Xindian, joint actual controller determination, nominee shareholding and equity incentives.
NewTimeSpace News: On 17 August 2026, Mech-Mind Robotics Technologies Co., Ltd. announced that it had passed the HKEX listing hearing on 16 August 2026, with CSC International and CITIC Securities as joint sponsors; the Company is a 3D-vision-and-AI driven smart robotics component supplier whose products have been sold in nearly 50 countries and regions worldwide.
NewTimeSpace News: On 17 August 2026, Hunan Yuneng (301358.SZ) submitted an H-share listing application to HKEX, with CSC International and HSBC as joint sponsors; the Company ranked first in global phosphate-based cathode material shipments for six consecutive years from 2020 to 2025 with a 28.2% market share in 2025; net profit attributable to shareholders grew 115.2% in 2025 and 1,337.8% in the first quarter of 2026.
NewTimeSpace News: On 17 August 2026, Ingenic Semiconductor (03223.HK) launched the global offering of H-shares, proposing to issue 31,287,300 H-shares at a maximum offer price of HK$102.80 per share; eleven cornerstone investors subscribed for an aggregate of approximately USD 192 million, representing approximately 46.74% of the offer shares.
NewTimeSpace News: The CSRC has issued an overseas listing filing notice, pursuant to which Hunan Junxin Environmental Protection Co., Ltd. plans to issue no more than 221,434,400 overseas listed ordinary shares and list on the HKEX.
NewTimeSpace News: The CSRC has issued an overseas listing filing notice, pursuant to which Shenzhen Transsion Holdings Co., Ltd. plans to issue no more than 132,386,200 overseas listed ordinary shares and list on the HKEX; the Company is required to report the offering status within 15 business days after completion and to update filing materials if the offering is not completed within 12 months, with the notice serving only as confirmation of the filing information and not constituting a judgment on investment value.
NewTimeSpace News: On 13 August, Hunan Junxin Environmental Protection Co., Ltd. submitted a listing application to the Main Board of the Stock Exchange of Hong Kong, with CICC and CITIC SEC acting as joint sponsors. The Company has been listed on the ChiNext of the Shenzhen Stock Exchange since 2022 (301109.SZ).
NewTimeSpace News: On 13 August 2026, Hunan Junxin Environmental Protection Co., Ltd. （301109.SZ）submitted a listing application to the HKEX Main Board for the third time, with CICC and CITIC SEC as joint sponsors; as a provider of comprehensive waste treatment and resource utilization solutions, the Company operates the Changsha Environmental Protection Industrial Park, one of the largest environmental parks in China, ranks first in China by average grid electricity per tonne of waste incinerated in 2025, with aggregate daily incineration capacity of 10,600 tonnes and food waste treatment capacity of 1,200 tonnes per day.
NewTimeSpace News: Zaihui Inc.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; Haitong International acted as the original sole sponsor. The Company is China's largest provider of online operations and marketing solutions for the F&B industry, having served 43,890 clients cumulatively as of 30 September 2025, with market shares of 9.8% and 14.4% on Xiaohongshu and Dianping respectively and the fastest growth rate among China's top three new media solutions providers in 2024.
NewTimeSpace News: VivaVision Biotech (Zhejiang) Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; CICC acted as the original sole sponsor. Both core products have initiated Phase III clinical trials in China: VVN461 (high dose), a novel JAK1/TYK2 dual-target inhibitor for non-infectious anterior uveitis, and VVN001, a second-generation LFA-1 antagonist for dry eye disease; the Company plans to submit an IND amendment in Q2 2026 and initiate VVN461 (high dose) Phase III in the US by the end of 2026.
NewTimeSpace News: Hunan Junxin Environmental Protection Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; CICC and CITIC Securities acted as the original joint sponsors. Ranked by average grid-connected electricity per tonne of waste, the Company ranked first among all waste-to-energy enterprises in China in 2024, operating the Changsha Environmental Protection Industrial Park with a daily treatment capacity of 10,600 tonnes, and has expanded into Central Asian markets including Kyrgyzstan and Kazakhstan.
NewTimeSpace News: ProteLight Pharmaceuticals (Jiangsu) Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; CITIC Securities acted as the original sole sponsor. Core product PL-5 (Peceleganan) is the world's first ganan-class drug to have a new drug application submitted, developed under the membrane discrimination mechanism theory, with the NDA submitted in China in 2024 and a Phase II trial ongoing in the US; the Company had nine candidates across four therapeutic areas as of the latest practicable date.
NewTimeSpace News: Shenzhen Immunofoco Biotechnology Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; Huatai International acted as the original sole sponsor. Core product IMC002, a potentially best-in-class anti-CLDN18.2 CAR-T cell therapy candidate ranking second globally in clinical progress, is in pivotal Phase III; the global CAR-T cell therapy market is expected to grow from USD 4.7 billion in 2024 to USD 35.2 billion in 2035.
NewTimeSpace News: Shenzhen Hai Robotics Innovation Intelligent Technology Group Co., Ltd.'s listing application filed with HKEX on 13 February 2026 has lapsed after six months; Goldman Sachs and CITIC Securities acted as the original joint sponsors. According to CIC, in 2024 the Company was the world's largest provider of ACR (automated case-handling robot) solutions, with a market share of over 30% by revenue and shipment volume, covering more than 40 countries and regions; orders from markets outside mainland China accounted for over 50% for the nine months ended 30 September 2025.
NewTimeSpace News: Nanjing Novlead Biotechnology Co., Ltd. filed with HKEX on 13 February 2026 with CCB International as sole sponsor, which lapsed after six months. The Company is the world's only enterprise covering a complete product line across NO therapeutic and diagnostic applications; core product iNOwill is the world's first electrochemical catalytic iNO therapy device (No. 1 by market share in China's iNO therapy market in 2024), with 5 approved products and 4 pipeline candidates.
